Filing Details

Accession Number:
0001104659-22-021075
Form Type:
13G Filing
Publication Date:
2022-02-13 19:00:00
Filed By:
Radcliffe Capital Management, L.p.
Company:
Sab Biotherapeutics Inc.
Filing Date:
2022-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Radcliffe Capital Management 0 627,555 0 627,555 627,555 1.44 %
RGC Management Company 0 627,555 0 627,555 627,555 1.44 %
Steven B. Katznelson 0 627,555 0 627,555 627,555 1.44 %
Christopher Hinkel 0 627,555 0 627,555 627,555 1.44 %
Radcliffe SPAC Master Fund 0 627,555 0 627,555 627,555 1.44 %
Radcliffe SPAC GP 0 627,555 0 627,555 627,555 1.44 %
Filing

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G*

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2

(Amendment No. 1)*

 

SAB Biotherapeutics, Inc.
(Name of Issuer)
 
Common stock, par value $0.0001 per share

(Title of Class of Securities)

 

78397T103
(CUSIP Number)
 
December 31, 2021
(Date of Event Which Requires Filing of the Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

Radcliffe Capital Management, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

IA, PN

       

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

RGC Management Company, LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

HC, OO

       

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

Steven B. Katznelson

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Canada, United States of America and the United Kingdom

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

HC, IN

       

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

Christopher Hinkel

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

HC, IN

       

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

Radcliffe SPAC Master Fund, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

OO, PN

       

 

 

 

 

1.

NAME OF REPORTING PERSONS

 

Radcliffe SPAC GP, LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

627,555

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

627,555

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

627,555

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.44%

12.

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

HC, OO

       

 

 

 

 

Item 1(a).

Name of Issuer:

SAB Biotherapeutics, Inc.

   
Item 1(b).

Address of Issuer’s Principal Executive Offices:

2100 East 54th Street North
Sioux Falls, South Dakota 57104

   
Item 2(a). Name of Person Filing:
 

Radcliffe Capital Management, L.P.

RGC Management Company, LLC

Steven B. Katznelson

Christopher Hinkel

Radcliffe SPAC Master Fund, L.P.

Radcliffe SPAC GP, LLC

   
Item 2(b). Address of Principal Business Office or, if none, Residence:
 

50 Monument Road, Suite 300

Bala Cynwyd, PA 19004

   
Item 2(c). Citizenship:
 

Radcliffe Capital Management, L.P. – Delaware, United States of America

RGC Management Company, LLC – Delaware, United States of America

Steven B. Katznelson – Canada, United States of America and the United Kingdom

Christopher Hinkel – United States of America

Radcliffe SPAC Master Fund, L.P. – Cayman Islands

Radcliffe SPAC GP, LLC – Delaware, United States of America

   
Item 2(d). Title of Class of Securities:
  546,658 shares of common stock, par value $0.0001 per share and 80,897 warrants, each warrant representing one share of common stock
   
Item 2(e). CUSIP Number:
  78397T103
   
Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
  (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
  (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
  (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
  (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________.

 

 

 

 

Item 4. Ownership:
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
   
  (a)

Amount beneficially owned:

 

627,555 shares deemed beneficially owned by Radcliffe Capital Management, L.P.

627,555 shares deemed beneficially owned by RGC Management Company, LLC

627,555 shares deemed beneficially owned by Steven B. Katznelson

627,555 shares deemed beneficially owned by Christopher Hinkel

627,555 shares deemed beneficially owned by Radcliffe SPAC Master Fund, L.P.

627,555 shares deemed beneficially owned by Radcliffe SPAC GP, LLC

     
  (b)

Percent of class:

 

1.44% shares deemed beneficially owned by Radcliffe Capital Management, L.P.

1.44% shares deemed beneficially owned by RGC Management Company, LLC

1.44% shares deemed beneficially owned by Steven B. Katznelson

1.44% shares deemed beneficially owned by Christopher Hinkel

1.44% shares deemed beneficially owned by Radcliffe SPAC Master Fund, L.P.

1.44% shares deemed beneficially owned by Radcliffe SPAC GP, LLC

     
  (c) Number of shares as to which Radcliffe Capital Management, L.P. has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       
    Number of shares as to which RGC Management Company, LLC has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       

 

 

 

    Number of shares as to which Steven B. Katznelson has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       
    Number of shares as to which Christopher Hinkel has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       
    Number of shares as to which Radcliffe SPAC Master Fund, L.P. has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       
    Number of shares as to which Radcliffe SPAC GP, LLC has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 627,555
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 627,555
       
Item 5. Ownership of Five Percent or Less of a Class:
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. x
   
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
  Not applicable
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
  See Exhibit B attached hereto.

 

 

 

 

Item 8. Identification and Classification of Members of the Group:
  Not applicable
   
Item 9. Notice of Dissolution of Group:
  Not applicable
   
Item 10. Certifications:
  By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  February 14, 2022
  (Date)
   

 

 

Radcliffe Capital Management, L.P.

By RGC Management Company, LLC,

its General Partner*

 

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

 

RGC Management Company, LLC*   /s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**
     
     
Steven B. Katznelson*  

/s/ Loretta Best
Signature
Attorney-in Fact**

 

 

Christopher Hinkel*  

/s/ Loretta Best
Signature
Attorney-in Fact**

 

 

Radcliffe SPAC Master Fund, L.P.

By Radcliffe SPAC GP, LLC,

its General Partner*

 

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

 

Radcliffe SPAC GP, LLC*  

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

*The Reporting Person specifically disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

 

**Loretta Best is signing on behalf of Steven B. Katznelson and Christopher Hinkel as attorney-in-fact pursuant to powers of attorney filed with the Securities and Exchange Commission as Exhibits 99.1 and 99.2, respectively, to a filing by Radcliffe Capital Management, L.P. on Schedule 13G on August 30, 2021.

 

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, Provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations

(see 18 U.S.C. 1001).

 

 

 

 

Exhibit A

 

Agreement

 

 

The undersigned agree that this Schedule 13G dated February 14, 2022 to the Common stock, par value $0.0001 per share of SAB Biotherapeutics, Inc. shall be filed on behalf of the undersigned.

 

  February 14, 2022
  (Date)
   

 

 

Radcliffe Capital Management, L.P.

By RGC Management Company, LLC,

Its General Partner

 

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

 

RGC Management Company, LLC   /s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**
     
     
Steven B. Katznelson  

/s/ Loretta Best
Signature
Attorney-in Fact**

 

 

Christopher Hinkel  

/s/ Loretta Best
Signature
Attorney-in Fact**

 

 

Radcliffe SPAC Master Fund, L.P.

By Radcliffe SPAC GP, LLC,

its General Partner

 

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

 

Radcliffe SPAC GP, LLC  

/s/ Loretta Best
Signature
Attorney-in Fact for Steven B. Katznelson
Managing Member**

 

**Loretta Best is signing on behalf of Steven B. Katznelson and Christopher Hinkel as attorney-in-fact pursuant to powers of attorney filed with the Securities and Exchange Commission as Exhibits 99.1 and 99.2, respectively, to a filing by Radcliffe Capital Management, L.P. on Schedule 13G on August 30, 2021.

 

 

 

 

Exhibit B

 

Radcliffe Capital Management, L.P. is the relevant entity for which RGC Management Company, LLC, Steven B. Katznelson and Christopher Hinkel may be considered control persons. Radcliffe SPAC Master Fund, L.P. is the relevant entity for which Radcliffe SPAC GP, LLC, Steven B. Katznelson and Christopher Hinkel may be considered control persons.